Document/ExhibitDescriptionPagesSize
1: 10-Q Quarterly Report HTML 1.31M
2: EX-10.E Material Contract HTML 185K
3: EX-10.F Material Contract HTML 187K
4: EX-10.J Material Contract HTML 365K
5: EX-10.KK Material Contract HTML 50K
6: EX-31.A Certification -- §302 - SOA'02 HTML 21K
7: EX-31.B Certification -- §302 - SOA'02 HTML 21K
8: EX-32.A Certification -- §906 - SOA'02 HTML 18K
9: EX-32.B Certification -- §906 - SOA'02 HTML 18K
15: R1 Cover Page HTML 69K
16: R2 Consolidated Statements of Operations HTML 84K
17: R3 Consolidated Statements of Comprehensive Income HTML 43K
18: R4 Consolidated Statements of Financial Position HTML 121K
19: R5 Consolidated Statements of Financial Position HTML 35K
(Parenthetical)
20: R6 Consolidated Statements of Cash Flows HTML 96K
21: R7 Consolidated Statements of Shareholders' HTML 86K
Investment
22: R8 Consolidated Statements of Shareholders' HTML 19K
Investment (Parenthetical)
23: R9 Accounting Policies HTML 20K
24: R10 Dermstore Sale HTML 19K
25: R11 Revenues HTML 60K
26: R12 Fair Value Measurements HTML 46K
27: R13 Property and Equipment HTML 20K
28: R14 Commercial Paper and Long-Term Debt HTML 23K
29: R15 Derivative Financial Instruments HTML 40K
30: R16 Income Taxes HTML 22K
31: R17 Share Repurchase HTML 30K
32: R18 Pension Benefits HTML 40K
33: R19 Accumulated Other Comprehensive Income (Loss) HTML 32K
34: R20 Accounting Policies (Policies) HTML 22K
35: R21 Revenues (Tables) HTML 57K
36: R22 Fair Value Measurements (Tables) HTML 47K
37: R23 Derivative Financial Instruments (Tables) HTML 38K
38: R24 Share Repurchase (Tables) HTML 30K
39: R25 Pension Benefits (Tables) HTML 36K
40: R26 Accumulated Other Comprehensive Income (Loss) HTML 31K
(Tables)
41: R27 Dermstore Sale (Details) HTML 26K
42: R28 Revenues - Disaggregation of Revenue (Details) HTML 45K
43: R29 Revenues - Narrative (Details) HTML 19K
44: R30 Revenues - Gift Card Liability (Details) HTML 23K
45: R31 Fair Value Measurements - Schedule of Fair Value HTML 37K
Measurements - Recurring Basis (Details)
46: R32 Fair Value Measurements - Schedule of Significant HTML 24K
Financial Instruments not Measured at Fair Value
(Details)
47: R33 Property and Equipment (Details) HTML 19K
48: R34 Commercial Paper and Long-Term Debt (Details) HTML 26K
49: R35 Derivative Financial Instruments - Narrative HTML 26K
(Details)
50: R36 Derivative Financial Instruments - Effect of HTML 22K
Hedges on Debt (Details)
51: R37 Derivative Financial Instruments - Effect of HTML 23K
Hedges on Net Interest Expense (Details)
52: R38 Income Taxes (Details) HTML 19K
53: R39 Share Repurchase - Schedule of Activity (Details) HTML 27K
54: R40 Pension Benefits (Details) HTML 37K
55: R41 Accumulated Other Comprehensive Income (Loss) HTML 40K
(Details)
58: XML IDEA XML File -- Filing Summary XML 96K
56: XML XBRL Instance -- tgt-20220730_htm XML 1.01M
57: EXCEL IDEA Workbook of Financial Reports XLSX 70K
11: EX-101.CAL XBRL Calculations -- tgt-20220730_cal XML 114K
12: EX-101.DEF XBRL Definitions -- tgt-20220730_def XML 215K
13: EX-101.LAB XBRL Labels -- tgt-20220730_lab XML 804K
14: EX-101.PRE XBRL Presentations -- tgt-20220730_pre XML 445K
10: EX-101.SCH XBRL Schema -- tgt-20220730 XSD 77K
59: JSON XBRL Instance as JSON Data -- MetaLinks 250± 360K
60: ZIP XBRL Zipped Folder -- 0000027419-22-000027-xbrl Zip 422K
1.I have reviewed this Quarterly Report on Form 10-Q of Target Corporation;
2.Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure
controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.designed
such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.disclosed in this report any change in the registrant’s
internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and
the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
